Lexicon Pharmaceuticals Files 8-K
Ticker: LXRX · Form: 8-K · Filed: Jul 3, 2025
Sentiment: neutral
Topics: 8-K, disclosure
Related Tickers: LXRX
TL;DR
Lexicon (LXRX) filed an 8-K on 7/3/25, but details are scarce.
AI Summary
Lexicon Pharmaceuticals, Inc. filed an 8-K on July 3, 2025, reporting an event under 'Other Events'. The filing does not contain specific details about the event itself, only the reporting date and company information.
Why It Matters
This filing indicates a material event has occurred or is being disclosed by Lexicon Pharmaceuticals, requiring public notification.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure without immediate financial or operational implications detailed within the provided text.
Key Players & Entities
- LEXICON PHARMACEUTICALS, INC. (company) — Registrant
- July 3, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 2445 Technology Forest Blvd., 11th Floor The Woodlands , Texas 77381 (address) — Principal Executive Offices
FAQ
What specific event is Lexicon Pharmaceuticals reporting in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported, only that the filing was made on July 3, 2025.
What is the filing date of this 8-K?
The filing date of this 8-K report is July 3, 2025.
Under which section of the 8-K is this event being reported?
This event is being reported under the 'Other Events' section of the 8-K filing.
What is the principal executive office address for Lexicon Pharmaceuticals?
The principal executive office address is 2445 Technology Forest Blvd., 11th Floor, The Woodlands, Texas 77381.
What is the company's state of incorporation?
Lexicon Pharmaceuticals, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 3, 2025 regarding LEXICON PHARMACEUTICALS, INC. (LXRX).